NO20044153L - 3-heteroaryl-3,5-dihydro-4-okso-4H-pyridazino[4,5-b]indol-1-acetamid-derivater, fremstilling og anvendelse derav i medikamenter - Google Patents

3-heteroaryl-3,5-dihydro-4-okso-4H-pyridazino[4,5-b]indol-1-acetamid-derivater, fremstilling og anvendelse derav i medikamenter

Info

Publication number: NO20044153L
Authority: NO; Norway
Prior art keywords: sub; pyridazino; indole; medicaments; dihydro
Prior art date: 2002-04-03

Application number

NO20044153A

Other languages

English (en)

Other versions

NO329426B1 (no

Inventor

Jacques Froissant

Frederic Puech

Frank Marguet

Benoit Marabout

Original Assignee

Sanofi Aventis

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-04-03

Filing date

2004-09-30

Publication date

2004-12-27

2004-09-30 Application filed by Sanofi Aventis filed Critical Sanofi Aventis

2004-12-27 Publication of NO20044153L publication Critical patent/NO20044153L/no

2010-10-18 Publication of NO329426B1 publication Critical patent/NO329426B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Immunology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Rheumatology (AREA)
Urology & Nephrology (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Obesity (AREA)
Psychology (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Endocrinology (AREA)
Hematology (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Indole Compounds (AREA)

NO20044153A 2002-04-03 2004-09-30 3-heteroaryl-3,5-dihydro-4-okso-4H-pyridazino[4,5-b]indol-1-acetamid-derivater, farmasoytiske preparater omfattende slike, fremgangsmater for fremstilling derav og syntese-mellomprodukter derav NO329426B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR0204158A FR2838124B1 (fr)	2002-04-03	2002-04-03	Derives de 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino [4,5-b]indole-1-acetamide, leur preparation et leur application en therapeutique
PCT/FR2003/001027 WO2003082874A2 (fr)	2002-04-03	2003-04-02	DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO[4,5-b]INDOLE-1-ACETAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

Publications (2)

Publication Number	Publication Date
NO20044153L true NO20044153L (no)	2004-12-27
NO329426B1 NO329426B1 (no)	2010-10-18

Family

ID=28052083

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20044153A NO329426B1 (no)	2002-04-03	2004-09-30	3-heteroaryl-3,5-dihydro-4-okso-4H-pyridazino[4,5-b]indol-1-acetamid-derivater, farmasoytiske preparater omfattende slike, fremgangsmater for fremstilling derav og syntese-mellomprodukter derav

Country Status (28)

Country	Link
US (4)	US7235554B2 (no)
EP (1)	EP1492792B1 (no)
JP (2)	JP4575670B2 (no)
KR (1)	KR100975999B1 (no)
CN (2)	CN100543016C (no)
AT (1)	ATE321763T1 (no)
AU (1)	AU2003240930B2 (no)
BR (1)	BR0309018A (no)
CA (1)	CA2481460C (no)
CY (1)	CY1104998T1 (no)
DE (1)	DE60304327T2 (no)
DK (1)	DK1492792T3 (no)
EA (1)	EA007219B1 (no)
ES (1)	ES2261940T3 (no)
FR (1)	FR2838124B1 (no)
HR (1)	HRP20040911B1 (no)
IL (2)	IL164257A0 (no)
IS (1)	IS2483B (no)
ME (2)	MEP23708A (no)
MX (1)	MXPA04009635A (no)
NO (1)	NO329426B1 (no)
NZ (1)	NZ535741A (no)
PL (1)	PL372617A1 (no)
PT (1)	PT1492792E (no)
RS (1)	RS51244B (no)
UA (1)	UA77273C2 (no)
WO (1)	WO2003082874A2 (no)
ZA (1)	ZA200407945B (no)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US20080255065A1 (en) *	2004-08-18	2008-10-16	Genesense Technologies, Inc.	Small Interfering Rna Molecules Against Ribonucleotide Reductase and Uses Thereof
MX2008002366A (es) *	2005-08-19	2008-03-18	Schering Corp	Antagonistas triciclicos fusionados de mglur1 como agentes terapeuticos.
EP2391607A1 (en) *	2009-01-30	2011-12-07	AstraZeneca AB	Novel process for preparing carboxy-containing pyrazoleamido compounds 597
CN105330665B (zh) *	2015-11-04	2017-10-03	衡阳师范学院	一种抑制激肽释放酶klk7的化合物、制备方法和用途

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2754262B1 (fr) *	1996-10-08	1998-10-30	Synthelabo	Derives de 1h-pyrido[3,4-b]indole-4-carboxamide, leur preparation et leur application en therapeutique
FR2766823B1 (fr)	1997-07-30	1999-10-08	Synthelabo	Derives de 4-oxo-3,5-dihydro-4h-pyridazino[4,5-b] indole-1-acetamide, leur preparation et leur application en therapeutique
FR2788776B1 (fr) *	1999-01-26	2001-02-23	Synthelabo	Derives de 4-oxo-3, 5-dihydro-4h-pyridazino [4,5-b] indole-1 -carboxamide, leur preparation et leur application en therapeutique
FR2788696B1 (fr)	1999-01-26	2004-03-05	Synthelabo	Utilisation de derives de pyridazino [4,5-b] indole-1-acetamide pour la preparation de medicaments destines aux maladies du systeme nerveux central
FR2811990A1 (fr) *	2000-07-24	2002-01-25	Sanofi Synthelabo	DERIVES DE 1-(4-OXO-3,5-DIHYDRO-4H-PYRIDAZINO[4,5-b]INDOLE-1 -CARBONYL)PIPERAZINE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE
FR2811897A1 (fr) *	2000-07-24	2002-01-25	Sanofi Synthelabo	UTILISATION DE DERIVES DE PYRIDAZINO[4,5-b]INDOLE-1- ACETAMIDE POUR LA PREPARATION DE MEDICAMENTS DESTINES AU TRAITEMENT DES DYSFONCTIONNEMENTS DES RECEPTEURS DE TYPE PERIPHERIQUE AUX BENZODIAZEPINES
FR2833953B1 (fr) *	2001-12-21	2004-12-03	Sanofi Synthelabo	DERIVES DE 3-HETEROARYL-3,5-DIHYDRO-4-OXO-4H-PYRIDAZINO [4,5-b]INDOLE-1-CARBOXAMIDE, LEUR PREPARATION ET LEUR APPLICATION EN THERAPEUTIQUE

2002
- 2002-04-03 FR FR0204158A patent/FR2838124B1/fr not_active Expired - Fee Related
2003
- 2003-02-04 UA UA20041008012A patent/UA77273C2/uk unknown
- 2003-04-02 PL PL03372617A patent/PL372617A1/xx unknown
- 2003-04-02 AU AU2003240930A patent/AU2003240930B2/en not_active Ceased
- 2003-04-02 ES ES03730299T patent/ES2261940T3/es not_active Expired - Lifetime
- 2003-04-02 ME MEP-237/08A patent/MEP23708A/xx unknown
- 2003-04-02 WO PCT/FR2003/001027 patent/WO2003082874A2/fr not_active Ceased
- 2003-04-02 CA CA2481460A patent/CA2481460C/en not_active Expired - Fee Related
- 2003-04-02 AT AT03730299T patent/ATE321763T1/de active
- 2003-04-02 BR BR0309018-3A patent/BR0309018A/pt not_active IP Right Cessation
- 2003-04-02 MX MXPA04009635A patent/MXPA04009635A/es active IP Right Grant
- 2003-04-02 DK DK03730299T patent/DK1492792T3/da active
- 2003-04-02 EA EA200401146A patent/EA007219B1/ru not_active IP Right Cessation
- 2003-04-02 JP JP2003580339A patent/JP4575670B2/ja not_active Expired - Fee Related
- 2003-04-02 ME MEP-2008-237A patent/ME00081B/me unknown
- 2003-04-02 EP EP03730299A patent/EP1492792B1/fr not_active Expired - Lifetime
- 2003-04-02 US US10/509,695 patent/US7235554B2/en not_active Expired - Lifetime
- 2003-04-02 NZ NZ535741A patent/NZ535741A/en not_active IP Right Cessation
- 2003-04-02 KR KR1020047015629A patent/KR100975999B1/ko not_active Expired - Fee Related
- 2003-04-02 CN CNB2006101003182A patent/CN100543016C/zh not_active Expired - Fee Related
- 2003-04-02 CN CNB038122227A patent/CN100406459C/zh not_active Expired - Fee Related
- 2003-04-02 HR HRP20040911 patent/HRP20040911B1/xx not_active IP Right Cessation
- 2003-04-02 IL IL16425703A patent/IL164257A0/xx unknown
- 2003-04-02 PT PT03730299T patent/PT1492792E/pt unknown
- 2003-04-02 RS YUP-869/04A patent/RS51244B/sr unknown
- 2003-04-02 DE DE60304327T patent/DE60304327T2/de not_active Expired - Lifetime
2004
- 2004-09-23 IL IL164257A patent/IL164257A/en not_active IP Right Cessation
- 2004-09-30 NO NO20044153A patent/NO329426B1/no not_active IP Right Cessation
- 2004-09-30 IS IS7478A patent/IS2483B/is unknown
- 2004-10-01 ZA ZA2004/07945A patent/ZA200407945B/en unknown
2006
- 2006-06-29 CY CY20061100885T patent/CY1104998T1/el unknown
2007
- 2007-05-16 US US11/749,342 patent/US7323467B2/en not_active Expired - Lifetime
- 2007-10-04 US US11/867,366 patent/US7405306B2/en not_active Expired - Fee Related
2008
- 2008-06-20 US US12/143,059 patent/US20080255129A1/en not_active Abandoned
2010
- 2010-06-22 JP JP2010141683A patent/JP5277208B2/ja not_active Expired - Fee Related

Also Published As

Publication number	Publication date
PL372617A1 (en)	2005-07-25
US20080255129A1 (en)	2008-10-16
JP4575670B2 (ja)	2010-11-04
IL164257A (en)	2009-11-18
IS7478A (is)	2004-09-30
CN100543016C (zh)	2009-09-23
AU2003240930B2 (en)	2009-07-30
DE60304327D1 (de)	2006-05-18
US20050124615A1 (en)	2005-06-09
DE60304327T2 (de)	2006-12-28
CN1970538A (zh)	2007-05-30
US20070219202A1 (en)	2007-09-20
US7235554B2 (en)	2007-06-26
EA007219B1 (ru)	2006-08-25
IS2483B (is)	2008-12-15
JP2010248221A (ja)	2010-11-04
JP2005527566A (ja)	2005-09-15
US7405306B2 (en)	2008-07-29
UA77273C2 (en)	2006-11-15
KR100975999B1 (ko)	2010-08-17
RS51244B (sr)	2010-12-31
EP1492792A2 (fr)	2005-01-05
MXPA04009635A (es)	2005-07-13
WO2003082874A2 (fr)	2003-10-09
MEP23708A (en)	2010-06-10
JP5277208B2 (ja)	2013-08-28
AU2003240930A1 (en)	2003-10-13
NO329426B1 (no)	2010-10-18
PT1492792E (pt)	2006-08-31
EA200401146A1 (ru)	2005-06-30
FR2838124A1 (fr)	2003-10-10
CN100406459C (zh)	2008-07-30
HK1074632A1 (zh)	2005-11-18
KR20040094904A (ko)	2004-11-10
CA2481460A1 (en)	2003-10-09
EP1492792B1 (fr)	2006-03-29
CN1656099A (zh)	2005-08-17
CA2481460C (en)	2011-02-15
ATE321763T1 (de)	2006-04-15
HRP20040911B1 (en)	2012-11-30
IL164257A0 (en)	2005-12-18
DK1492792T3 (da)	2006-08-14
US20080076775A1 (en)	2008-03-27
RS86904A (sr)	2006-12-15
FR2838124B1 (fr)	2004-05-28
HRP20040911A2 (en)	2004-12-31
HK1102371A1 (en)	2007-11-16
WO2003082874A3 (fr)	2004-04-01
ES2261940T3 (es)	2006-11-16
NZ535741A (en)	2007-03-30
ME00081B (me)	2010-10-10
BR0309018A (pt)	2005-02-01
CY1104998T1 (el)	2009-11-04
ZA200407945B (en)	2005-11-30
US7323467B2 (en)	2008-01-29

Publication	Publication Date	Title
HRP20020712B1 (hr)	2012-11-30	Farmaceutske strukture koje sadrže derivate azetidina, novi derivati azetidina i njihovo pripremanje
HUP0303398A2 (hu)	2004-03-01	1,2-Dihidropiridin-származékok, eljárás előállításukra és alkalmazásuk és a vegyületeket tartalmazó gyógyszerkészítmények
CY1111822T1 (el)	2015-10-07	Παραγωγα σπειροϊνδολινοπιπεριδινης ονες
TR200102490T2 (tr)	2001-12-21	Fenil ve piridinil türevleri
ATE300540T1 (de)	2005-08-15	Imidazopyridin-derivate
TW200504061A (en)	2005-02-01	Pyrazolopyridine derivatives
HUP0400202A2 (hu)	2004-08-30	Metalloproteináz inhibitor, hatású imidazolidin-dion-származékok alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
ATE316083T1 (de)	2006-02-15	Adamantanderivate
SE9904738D0 (sv)	1999-12-22	Novel compounds
GB0124933D0 (en)	2001-12-05	Chemical compounds
DE69023321D1 (de)	1995-12-07	Antipicornaviral-Pyridazinamine.
DK393486A (da)	1987-02-22	Dihydropyridin-derivater og fremgangsmaade til fremstilling deraf
NO20044153L (no)	2004-12-27	3-heteroaryl-3,5-dihydro-4-okso-4H-pyridazino[4,5-b]indol-1-acetamid-derivater, fremstilling og anvendelse derav i medikamenter
TW200607808A (en)	2006-03-01	Pyrido-pyrimidine derivatives, preparation thereof and application thereof
YU49902A (sh)	2005-03-15	Supstituisani derivati piperazina kao mtp inhibitori
CY1106029T1 (el)	2011-04-06	Παραγωγα 3-ετepοαρυλιο-3,5-διυδρο-4-οξο-4η-πυριδαζινο[4,5-β]ινδολη-1-καρβοξαμιδο, η παρασκευη τους και η εφαρμογη τους στη θepαπευτικη
NO20022123L (no)	2002-05-03	Osoksazolderivater for anvendelse som inhibitorer for fosfodiesterase VII
WO2005095399A3 (fr)	2006-06-01	Derives pyrrolo (2,3-b) pyridine, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
NO20041704L (no)	2004-04-26	Substituerte alkylaminopyridazinonderivater, fremgangsmater for deres fremstilling og farmasoytiske sammensetninger som inneholder disse
HK1042288A1 (zh)	2002-08-09	6-[[(芳基和雜芳基)氧]甲基]-萘基-2-甲亞胺酸酰胺衍生物，其製備方法及其在治療方面的應用
CO5631444A2 (es)	2006-04-28	Derivados 3-heteroaril-3,5-dihidro-4-oxo-4h-piridazino [4,5- b] indol-1-ecetamida
GR1001123B (el)	1993-04-28	Μεθοδος παρασκευης 1,4-διυδροπυριδινων.
TH63265A (th)	2004-08-09	อนุพันธ์ 3-เฮตเทอโรแอริล-3,5-ไดไฮโดร-4-ออกโซ-4H-ไพริดาซิโน[4,5-b] -อินโดล-1-คาร์บอกซามีด การเตรียมและการประยุกต์ในการรักษาโรค

Legal Events

Date	Code	Title	Description
2005-12-12	RE	Reestablishment of rights (par. 72 patents act)
2014-11-24	MM1K	Lapsed by not paying the annual fees